Pangestyme CN 20 Alternatives Compared
| Pangestyme CN 20 (pancrelipase) | Pulmozyme (dornase alfa) | Creon (pancrelipase) |
|
|---|
| Pangestyme CN 20 (pancrelipase) | Pulmozyme (dornase alfa) | Creon (pancrelipase) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pancreatic Exocrine Dysfunction, Chronic Pancreatitis, Cystic Fibrosis. Pangestyme CN 20 may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Cystic Fibrosis. Pulmozyme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pancreatic Exocrine Dysfunction, Chronic Pancreatitis, Cystic Fibrosis. Creon may also be used for purposes not listed in this medication guide. |
Related suggestions Cystic Fibrosis
|
|||||||||||||||
| More about (pancrelipase) | More about Pulmozyme (dornase alfa) | More about Creon (pancrelipase) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Pulmozyme has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Creon has an average rating of 6.4 out of 10 from a total of 61 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 28% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Pangestyme CN 20 side effects |
View all Pulmozyme side effects |
View all Creon side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Pulmozyme prices |
View all Creon prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other pancrelipase brands include: Creon, Pancreaze, Pertzye, Viokace, Zenpep |
N/A |
Other pancrelipase brands include: Pancreaze, Pertzye, Viokace, Zenpep | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
11 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 26 drugs are known to interact with Pangestyme CN 20:
|
A total of 1 drugs are known to interact with Pulmozyme:
|
A total of 26 drugs are known to interact with Creon:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
December 30, 1993 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.